BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24833402)

  • 1. Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer.
    Deng J; Liang H; Ying G; Zhang R; Wang B; Yu J; Fan D; Hao X
    Oncotarget; 2014 May; 5(10):3173-83. PubMed ID: 24833402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer.
    Xie XM; Deng JY; Hou YC; Cui JL; Wu WP; Ying GG; Dong QP; Hao XS; Liang H
    Cancer Biomark; 2015; 15(3):259-65. PubMed ID: 25769451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer.
    Deng J; Liang H; Zhang R; Dong Q; Hou Y; Yu J; Fan D; Hao X
    Oncotarget; 2014 Sep; 5(17):7420-30. PubMed ID: 25277182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter.
    Deng J; Guo J; Guo X; Hou Y; Xie X; Sun C; Zhang R; Yu X; Liang H
    Oncotarget; 2016 Jul; 7(28):43461-43474. PubMed ID: 27223257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang R; Yu J; Fan D; Hao X
    Oncotarget; 2015 Feb; 6(6):4482-95. PubMed ID: 25714013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
    Han F; Sun LP; Liu S; Xu Q; Liang QY; Zhang Z; Cao HC; Yu J; Fan DM; Nie YZ; Wu KC; Yuan Y
    Oncotarget; 2016 Apr; 7(17):24800-9. PubMed ID: 27050149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
    J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
    Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
    Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer.
    Cheung KF; Lam CN; Wu K; Ng EK; Chong WW; Cheng AS; To KF; Fan D; Sung JJ; Yu J
    Cancer; 2012 Feb; 118(4):947-59. PubMed ID: 21717426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
    Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
    Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Dig Dis Sci; 2010 Dec; 55(12):3449-57. PubMed ID: 20397048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.
    Otani K; Dong Y; Li X; Lu J; Zhang N; Xu L; Go MY; Ng EK; Arakawa T; Chan FK; Sung JJ; Yu J
    J Pathol; 2014 Nov; 234(3):302-15. PubMed ID: 24931004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancer.
    Deng J; Liang H; Zhang R; Hou Y; Liu Y; Ying G; Pan Y; Hao X
    Br J Surg; 2016 Mar; 103(4):407-16. PubMed ID: 26805552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
    Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
    Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis.
    Lu ZM; Zhou J; Wang X; Guan Z; Bai H; Liu ZJ; Su N; Pan K; Ji J; Deng D
    PLoS One; 2012; 7(4):e35928. PubMed ID: 22558275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of High-Frequency Methylation Sites in RNF180 Promoter Region Affecting Expression and Their Relationship with Prognosis of Gastric Cancer.
    Han F; Liu S; Jing J; Li H; Yuan Y; Sun LP
    Cancer Manag Res; 2020; 12():3389-3399. PubMed ID: 32494203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
    Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
    Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo.
    Du Y; Liu Z; Gu L; Zhou J; Zhu BD; Ji J; Deng D
    BMC Cancer; 2012 Jun; 12():249. PubMed ID: 22703336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
    Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
    PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.